A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Alexion Pharmaceuticals, Inc.
Universitaire Ziekenhuizen KU Leuven
University of Texas Southwestern Medical Center
University of Alabama at Birmingham
Mayo Clinic
University of Alabama at Birmingham
UNC Lineberger Comprehensive Cancer Center
Brigham and Women's Hospital
University Hospital, Essen
Nexcella Inc.
Fondazione IRCCS Policlinico San Matteo di Pavia
Fondazione IRCCS Policlinico San Matteo di Pavia
Fondazione IRCCS Policlinico San Matteo di Pavia
xCures
Sanguine Biosciences
Nanjing University School of Medicine
Peking University First Hospital